AZN ▼ -1.3% - AstraZeneca PLC $AZN - Talk FDA Grants Accelerated Approval to a New Breast Cancer Treatment (SM Circulations) AstraZeneca fell 1.3% today despite the company receiving FDA accelerated approval for a new breast cancer treatment. The decline suggests investors may have been expecting a stronger market reaction to the regulatory milestone, or broader market headwinds outweighed the positive news. 04-SEP-2026 03:40 PM ET